Leadership team

Mike joined Shire in July 2005 from Safeguard Scientifics, Inc., where he was President of its Life Sciences division. He joined Safeguard in 2000 and is on the board of several of its life science companies. Between 1992-2000, Michael worked for AstraMerck/AstraZeneca and, as one of the earliest employees of AstraMerck, was responsible for developing the new company's product development, medical affairs, business research, licensing and pharmaceutical business units. As Head of Product Development he was responsible for development and commercialization in the US.